Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296565 · ClinicalTrials.gov registry record · Phase 4
Water-based Activity to Enhance Recall in Veterans
A Phase 4 study of Mild Cognitive Impairment, sponsored by VA Office of Research and Development.
- Active
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
- 1
- Study location
NCT04296565: Active Phase 4 study of Mild Cognitive Impairment, sponsored by VA Office of Research and Development.
NCT04296565 is a Phase 4 study of Mild Cognitive Impairment that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 121 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04296565, a Phase 4 study of Mild Cognitive Impairment, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
- 1
- Study location
Study Summary
This four-year study will evaluate the efficacy of an exercise training augmentation for cognitive training intervention to improve memory performance in Veterans with a diagnosis of amnestic Mild Cognitive Impairment (aMCI). This is a two-phased trial: 1) an exercise phase and 2) a cognitive training program. The exercise phase will be an aquatic based exercise program. A combination of exercise and cognitive training programs designed for persons without cognitive impairment have significantly improved memory more than other single intervention groups (exercise only, cognitive training only) and given the success of combination training programs with healthy older adults, it is important to adapt these programs for persons beginning to exhibit clinically significant memory problems, such as those with aMCI.
Primary Outcome
The ADAS-Cog is a structured scale that evaluates multiple cognitive domains including: orientation, memory, reasoning, language, and praxis.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL WATER+CT
Study Locations (1)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
What the registry record for NCT04296565 still lists
NCT04296565 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT04296565 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04296565 about?
NCT04296565 is a clinical study titled "Water-based Activity to Enhance Recall in Veterans". This four-year study will evaluate the efficacy of an exercise training augmentation for cognitive training intervention to improve memory performance in Veterans with a diagnosis of amnestic Mild Cognitive Impairment (aMCI). This is a two-phased trial: 1) an exercise phase and 2) a cognitive traini...
What is the current status of trial NCT04296565?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2022-01-03. Estimated completion is 2026-06-30.
What conditions does trial NCT04296565 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment.
What interventions are being tested in trial NCT04296565?
The interventions under investigation include: Usual Care (BEHAVIORAL), WATER+CT (BEHAVIORAL).
Who is sponsoring clinical trial NCT04296565?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04296565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04296565's enrollment target sits among peer trials
121 77th of 205 higher than 128 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lithium As a Treatment to Prevent Impairment of Cognition in Elders
COMPLETED · Phase 4
-
Combination Treatment Study for Memory Impairment and Depression
COMPLETED · Phase 4
-
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
COMPLETED · Phase 4
-
Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia
COMPLETED · Phase 4
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI